Healthcare costs of NVAF patients treated with rivaroxaban and apixaban in the US
Milentijevic, Dejan, Germain, Guillaume, Laliberté, François, Bookhart, Brahim K., MacKnight, Sean D., Tsang, Jenkin, Lefebvre, PatrickJournal:
Journal of Medical Economics
DOI:
10.1080/13696998.2020.1821038
Date:
September, 2020
File:
PDF, 854 KB
2020